2013
DOI: 10.1016/j.biomaterials.2013.06.007
|View full text |Cite
|
Sign up to set email alerts
|

EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
75
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 135 publications
(75 citation statements)
references
References 30 publications
0
75
0
Order By: Relevance
“…Previous studies demonstrated that Cur can significantly inhibit the proliferation of glioma cells by downregulating multidrug resistance proteins that cause the efflux of many chemotherapeutic agents. 28,29 However, its clinical application is severely restricted due to its low water solubility.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies demonstrated that Cur can significantly inhibit the proliferation of glioma cells by downregulating multidrug resistance proteins that cause the efflux of many chemotherapeutic agents. 28,29 However, its clinical application is severely restricted due to its low water solubility.…”
Section: Discussionmentioning
confidence: 99%
“…Meanwhile, anticancer agents as well as therapeutic genes (e.g., DNA or siRNA) could be loaded in inorganic nanocarriers to achieve synergistic therapeutic effects due to their ease of surface modification (Figure 2A) 66. Moreover, inorganic nanocarriers could provide multifunctional platforms for cancer treatment, such as hyperthermia therapy,67, 68 which demonstrated potential to reverse MDR in cancers by combination with chemotherapy 69. More importantly, these inorganic nanocarriers could also provide molecular imaging function, which could help monitoring drug delivery processes and therapeutic outcomes, leading to improved treatment efficacy, especially for treating MDR cancers 70, 71…”
Section: Inorganic Nanocarriers Overcoming Drug Resistance For Cancermentioning
confidence: 99%
“…In addition, with high absorption in the NIR region, the GOs could be applied for tumor ablation by PTT. Thus, the drug‐loaded GOs were dual functionalized for chemotherapy and PTT to achieve synergistic effects, demonstrating a promising strategy to treat MDR cancers 69, 123, 124…”
Section: Inorganic Nanocarriers Overcoming Drug Resistance For Cancermentioning
confidence: 99%
“…[7][8][9] Other limitations of BCNU and temozolomide include their poor solubility, systemic toxicity, and short half-life in the human body. To date, many approaches have been proposed to improve the therapeutic effects of BCNU and enhance its stability, including polymeric nanoparticles (NPs), polymer biochips, magnetic NPs, graphene oxide, and liposomes, [10][11][12][13][14] but their safety and biocompatible issues still remain unclear. Albumin is the most abundant protein with a molecular weight of 66.5 kDa in plasma (35-50 g/L human serum), which is stable in a wide pH range (pH 4-9), biocompatible, biodegradable, nontoxic, and nonimmunogenic.…”
Section: Introductionmentioning
confidence: 99%